Unchained Labs
PrivateLast Round
Buyout/LBO
Apr 26, 2021
Est. Valuation
$435M
Total Funding Raised
$86M
Company Overview
Unchained Labs operates in Healthcare & Life Sciences and is based in Pleasanton, California. Its latest recorded funding round was a Series D round in March 2018.
Unchained Labs is a discovery tools (healthcare) company that provides problem-tackling solutions for biologics and gene therapy researchers.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Unchained Labs Comparables
Compare Unchained Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NanoTemper Technologies | 82% | |
| ProFoldBio | 76% | |
| Refeyn | 74% |
For institutional investors. Book with your work email.
Unchained Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Buyout/LBO | Apr 26, 2021 | ||||
| Series D | Mar 27, 2018 | ||||
| Series C | Jun 29, 2017 | ||||
| Series B | Feb 18, 2016 | ||||
| Series A | Feb 12, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Unchained Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Carlyle Group | Buyout/LBO |
| Novo Ventures | Series C, Series B, Series D, Series A |
| Canaan Partners | Series C, Series B, Series D, Series A |
| TPG Biotech | Series C, Series B, Series D, Series A |
| Tri-Valley Ventures | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 23, 2025
Monthly visitors grew 52% MoM, reaching 27.5K.
- Oct 29, 2024
Monthly visitors grew 75% MoM to 29.4K.
For institutional investors. Book with your work email.
Unchained Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Unchained Labs's valuation, stock price, and market status.
Is Unchained Labs a public or private company?
Unchained Labs is a private company.
What is the current stock price of Unchained Labs?
Unchained Labs is a private company, so its shares have no public market price. Caplight tracks Unchained Labs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Unchained Labs worth (valuation)?
Unchained Labs's valuation is estimated at $435.0M based on funding round data.
Can I buy Unchained Labs stock?
Unchained Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Unchained Labs's last funding round?
Unchained Labs's most recent funding round was Buyout/LBO on April 26, 2021.
Who are the main investors in Unchained Labs?
Key investors in Unchained Labs include The Carlyle Group, Novo Ventures, Canaan Partners, TPG Biotech.
Will Unchained Labs IPO soon?
No public IPO plans have been announced for Unchained Labs.
How can I track Unchained Labs secondary market activity?
Caplight tracks bids, offers, and trades in Unchained Labs's shares on secondary markets.